Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.

Journal of neuro-oncology(2023)

引用 0|浏览19
暂无评分
摘要
This study found no significant difference in OS between SEB and SIB for GBM patients treated with CCRT. Further research is needed to validate these findings and to determine the optimal boost techniques for this patient population.
更多
查看译文
关键词
glioblastoma multiforme,boost sequence,chemo-radiotherapy,idh-wildtype
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要